Additionally, studies have shown that certain retinoid drugs can inhibit tumor cell proliferation [36], further suggesting that RBP4 may act as a modulator of both metastatic potential and cell proliferation, particularly in the context of liver cancer. This evidence concerns the gene RBP4 and liver cancer.